Embryo Project Encyclopedia Articles

The Spemann-Mangold organizer, also known as the Spemann organizer, is a cluster of cells in the developing embryo of an amphibian that induces development of the central nervous system. Hilde Mangold was a PhD candidate who conducted the organizer experiment in 1921 under the direction of her graduate advisor, Hans Spemann, at the University of Freiburg in Freiburg, German. The discovery of the Spemann-Mangold organizer introduced the concept of induction in embryonic development. Now integral to the field of developmental biology, induction is the process by which the identity of certain cells influences the developmental fate of surrounding cells. Spemann received the Nobel Prize in Medicine in 1935 for his work in describing the process of induction in amphibians. The Spemann-Mangold organizer drew the attention of embryologists, and it spurred numerous experiments on the nature of induction in many types of developing embryos.

Although educated as a scientist who studied with both August Weismann and Ernst Heinrich Haeckel, Hans Adolf Eduard Driesch was first employed as a professor of philosophy and became a strong proponent of vitalism. Driesch was born on 28 October 1867, the only child of Josefine Raudenkolb and Paul Driesch. He grew up in a wealthy merchant family in Hamburg, Germany, where he was educated at the humanistic Gymnasium Gelehrtenschule des Johanneums that had been founded by a friend of Martin Luther. In 1886 he spent two summers studying with Weismann at the University of Freiburg and then entered the University of Jena, where he received his doctorate in 1889 with a study of hydroid colonies. By 1890 Driesch had lost interest in Haeckel's popular phylogenetic approach to zoology and instead focused on experimental embryology.

This video is composed of a sequence of films created by John Tyler Bonner in the 1940s to show the life cycle of the cellular slime mold Dictyostelium discoideum. As only the second person to study slime molds, Bonner frequently encountered audiences who had never heard of, let alone seen, the unusual organism. He therefore decided to create a film to present at seminars in order to introduce his object of study; the time-lapsed film captivated audiences, indeed Bonner has described that the film "always stole the show." Bonner began working in the biology department at Princeton University in 1947, and although Princeton appears in the opening title, Bonner actually made the film for his senior thesis as an undergraduate at Harvard University with some early assistance from Frank Smith, a photographer. Although unsure of name of the device that was used for filming, he has described it as "the most amazing antique contraption that belonged to my professor, Wm. H. Weston. It consisted of a gigantic and VERY heavy set of brass gears that had numerous possible speeds that turned a crank on the side of an old 16 mm box camera that pointed into the ocular of a microscope. The electric motor that propelled it made such vibrations that the whole apparatus had to be on a separate table and not touching the microscope."

Born in Ypsilanti, Michigan, on 2 February 1869, Charles Manning Child was the only surviving child of Mary Elizabeth and Charles Chauncey Child, a prosperous, old New England family. Growing up in Higganum, Connecticut, Child was interested in biology from an early age. He made extensive collections of plants and minerals on his family farm and went on to study biology at Wesleyan University, commuting from his family home. Child received his PhB in 1890 and MS in biology in 1892, and then went on to study in Leipzig after his parents death. He worked for a short time in the psychology laboratory of Wilhelm Wundt, and then pursued studies in zoology under the supervision of Rudolf Leuckhart. His doctoral dissertation investigated morphological aspects of insect sense organs. Leuckhart emphasized the functional purpose of morphological structures and led many of his students to develop and defend the notion of teleology, including Child, who completed his PhD in 1894.

Regeneration is a fascinating phenomenon. The fact that many organisms have the capacity to regenerate lost parts and even remake complete copies of themselves is difficult to fathom; so difficult, in fact, that for a very long time people were reluctant to believe regeneration actually took place. It seemed unbelievable that some organisms could re-grow lost limbs, organs, and other body parts. If only we could do the same! Unfortunately, our regenerative capacities are limited to hair, nails, and skin, while the liver and a few other tissues display more restricted regenerative abilities. What if we could grow back lost limbs, or damaged organs? This question has inspired many stories, dating back to Greek mythology, wherein Prometheus was doomed to regenerate his liver after it had been devoured by birds. Regeneration has permeated many imaginations; it has appeared in many literary and religious texts, and has also provoked much interest from the scientific community.

Human pluripotent stem cells are valued for their potential to form numerous specialized cells and for their longevity. In the US, where a portion of the population is opposed to destruction of human embryos to obtain stem cells, what avenues are open to scientists for obtaining pluripotent cells that do not offend the moral sensibilities of a significant number of citizens? It is this question that the official position paper, or white paper, "Alternative Sources of Human Pluripotent Stem Cells," published in May 2005 by the President's Council on Bioethics under the chairmanship of Leon Kass, seeks to answer. Three experts external to the council, Andrew Fire from the Stanford University School of Medicine, Markus Grompe of the Oregon Health and Science University, and Janet Rossant from the Samuel Lunenfeld Research Institute in Toronto, also reviewed the white paper prior to publication.

In 1914 Albert Niemann, a German pediatrician who primarily studied infant metabolism, published a description of an Ashkenazi Jewish infant with jaundice, nervous system and brain impairments, swollen lymph nodes (lymphadenopathy), and an enlarged liver and spleen (hepatosplenomegaly). He reported that these anatomical disturbances resulted in the premature death of the child at the age of eighteen months. After extensively studying the abnormal characteristics of the infant, Niemann came to the conclusion that the disease was a variant of Gaucher's disease. Gaucher's disease, described by the French dermatologist Philippe Gaucher in 1882, is a lipid storage disorder resulting in an excessive accumulation of lipids in the spleen, kidneys, liver, lungs, bone marrow, and brain. Niemann was able to connect the infant's disease to Gaucher's disease because it displayed similar symptoms: a noticeable accumulation of fatty substances in the brain, liver, and spleen.

Alejandro Sánchez Alvarado is a Professor of Neurobiology and Anatomy at the University of Utah School of Medicine and is also a Howard Hughes Medical Institute Investigator. Born in Caracas, Venezuela, 24 February 1964, Sánchez Alvarado left his home to pursue education in the United States, where he received a Bachelor of Science in molecular biology and chemistry from Vanderbilt University in 1986 and a Doctorate in pharmacology and cell biophysics at the University of Cincinnati College of Medicine in 1992. During his PhD studies Sánchez Alvarado examined the in vitro differentiation of mouse embryonic stem cells. In 1994 he began a postdoctoral position at the Carnegie Institution of Washington's Department of Embryology, where he was appointed a staff associate in 1995. In 2002 he became an Associate Professor at the University of Utah School of Medicine in the Department of Neurobiology and Anatomy, and was promoted to Professor in 2005.

Shinya Yamanaka gained international prominence after publishing articles detailing the successful generation of induced pluripotent stem (iPS) cells, first in mice, then in humans. Yamanaka induced somatic cells to act like human embryonic stem cells (hESCs), allowing researchers to experiment with non-embryonic stem cells with a similar capacity as hESCs. The research involving iPS cells therefore offered new potential for research and application in medical treatment, without many of the ethical objections that hESC research entailed.